Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the Asia-Pacific generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
The Asia-Pacific generics market is expected to generate total revenues of $147.4bn in 2016, representing a compound annual growth rate (CAGR) of 16.7% between 2012 and 2016.
Market consumption volume is forecast to increase with a CAGR of 1.1% between 2012 and 2016, to reach a total of 72.1% of total pharma volume in 2016.
The Asia-Pacific region’s strong growth is expected to continue as the region’s largest markets – China, Japan, and India – continue to push generic uptake in their own countries.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Asia-Pacific
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Asia-Pacific
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific generics market with five year forecasts by both value and volume
Reasons to buy
What was the size of the Asia-Pacific generics market by value in 2016?
What will be the size of the Asia-Pacific generics market in 2021?
What factors are affecting the strength of competition in the Asia-Pacific generics market?
How has the market performed over the last five years?
How large is Asia-Pacific’s generics market in relation to its regional counterparts?